- Home
- CIM vs OPK Comparison
CIM vs OPK Comparison
Compare CIM & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIM
- OPK
- Stock Information
- Founded
- CIM 2007
- OPK 2007
- Country
- CIM United States
- OPK United States
- Employees
- CIM N/A
- OPK N/A
- Industry
- CIM Real Estate Investment Trusts
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- CIM Real Estate
- OPK Health Care
- Exchange
- CIM Nasdaq
- OPK Nasdaq
- Market Cap
- CIM 1.2B
- OPK 1.0B
- IPO Year
- CIM 2007
- OPK 1995
- Fundamental
- Price
- CIM $15.21
- OPK $1.59
- Analyst Decision
- CIM Hold
- OPK Strong Buy
- Analyst Count
- CIM 2
- OPK 3
- Target Price
- CIM $16.00
- OPK $2.75
- AVG Volume (30 Days)
- CIM 485.8K
- OPK 2.9M
- Earning Date
- CIM 02-12-2025
- OPK 02-25-2025
- Dividend Yield
- CIM 9.37%
- OPK N/A
- EPS Growth
- CIM 117.60
- OPK N/A
- EPS
- CIM 3.36
- OPK N/A
- Revenue
- CIM $442,341,000.00
- OPK $711,408,000.00
- Revenue This Year
- CIM N/A
- OPK N/A
- Revenue Next Year
- CIM $10.53
- OPK $0.00
- P/E Ratio
- CIM $4.51
- OPK N/A
- Revenue Growth
- CIM 44.27
- OPK N/A
- 52 Week Low
- CIM $11.29
- OPK $0.86
- 52 Week High
- CIM $16.89
- OPK $1.76
- Technical
- Relative Strength Index (RSI)
- CIM 58.60
- OPK 60.76
- Support Level
- CIM $14.47
- OPK $1.47
- Resistance Level
- CIM $15.08
- OPK $1.51
- Average True Range (ATR)
- CIM 0.26
- OPK 0.04
- MACD
- CIM 0.09
- OPK 0.01
- Stochastic Oscillator
- CIM 67.74
- OPK 80.00
About CIM Chimera Investment Corporation
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.